Cargando…
Pembrolizumab-Induced Lichen Planus in a Patient With Non-Small-Cell Lung Carcinoma (NSCLC) That Correlates to Therapeutic Response
Immune checkpoint inhibitors are increasingly being used in the treatment of various solid organ and hematologic malignancies. Dermatologic toxicities associated with programmed cell death protein-1 (PD-1) and programmed death ligand-1 (PD-L1) therapy have been widely reported in the literature. Lic...
Autores principales: | Sehbai, Aasim, Hamid, Muhammad A, Ibrahim, Zainab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747249/ https://www.ncbi.nlm.nih.gov/pubmed/36523676 http://dx.doi.org/10.7759/cureus.31454 |
Ejemplares similares
-
Pembrolizumab-Induced Eruptive Keratoacanthomas and Lichen Planus in a Lung Cancer Patient
por: Tembunde, Yazmeen, et al.
Publicado: (2023) -
An Unusual Presentation of Lichen Planus
por: Sharma, Pranjali
Publicado: (2021) -
Scarring Alopecia With Coexisting Lichen Planus in a Child: A Rare Phenomenon
por: Hamid, Muhammad Ammar B, et al.
Publicado: (2021) -
Actinic Lichen Planus: Significance of Dermoscopic Assessment
por: Singh, Riddhima, et al.
Publicado: (2023) -
Inverse Lichen Planus Associated With Nail Dystrophy
por: Alrefaie, Yasser, et al.
Publicado: (2023)